跳至主要内容

Genotoxic and Cytotoxic Damage by Cyclophosphamide and Adriamycin as a Response to Treatment in Breast Cancer Patients: Pilot Study

Read  full  paper  at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53822#.VNR6JSzQrzE

ABSTRACT
The aim of this study was to evaluate the genotoxicity induced by cyclophosphamide-adriamycin treatment in breast cancer patients through the frequencies of Sister Chromatid Exchange (SCE), Replication Index (RI), Mitotic Index (MI) and Cell Proliferation Index (CPI) and to study the possible association between biomarkers of genotoxicity and the early response to treatment. The frequencies were obtained before and immediately after therapy from 17 patients with breast cancer (p < 0.001). Response to treatment was assessed after two years resulting in 12 patients in a state of remission. MI and CPI had high values after treatment in women with active cancers compared to those in a state of remission, however there were not significant differences. Conclusions: It is possible that MI y CPI biomarkers can serve as indicators for early assessment of treatment with cyclophosphamide-adriamycin. It should be noted that these are preliminary results and further study is necessary.
Cite this paper
Garibay-Garcia, J. , Mejia-Sanchez, F. , Ramírez-San-Juan, E. , Flores-Merino, M. and Castillo-Cadena, J. (2015) Genotoxic and Cytotoxic Damage by Cyclophosphamide and Adriamycin as a Response to Treatment in Breast Cancer Patients: Pilot Study. Journal of Cancer Therapy, 6, 163-168. doi: 10.4236/jct.2015.62018.
 
References
[1]Mohar, A., Bargallo, E., Ramírez, M.T., Lara, F. and Beltrán-Ortega, A. (2009) Recursos disponibles para el tratamiento del cáncer de mama en México. Salud Pública de México, 51, 263-269.
http://dx.doi.org/10.1590/S0036-36342009000800017
 
[2]Knaul, F.M., Nigenda, G., Lozano, R., Arreola-Ornelas, H., Langer, A. and Frenk, J. (2009) Cáncer de mama en México: Una prioridad apremiante. Salud Pública de México, 51, 335-344.
http://dx.doi.org/10.1590/S0036-36342009000800026
 
[3]Bland, I.K. and Copeland, E.M. (2000) La mama, manejo multidisciplinario de las enfermedades benignas y malignas. Médica Panamericana, Buenos Aires.
 
[4]Khosravi-Shahi, P., Izarzugaza-Perón, Y., Encinas-García, E., Díaz-Mu?oz-de-la-Espada, V.M. and Pérez Manga, G. (2008) Tratamiento adyuvante en el cáncer de mama operable. Anales de Medicina Interna, 25, 36-40. http://dx.doi.org/10.4321/S0212-71992008000100010
 
[5]Rodríguez-Reyes, R.G. (2000) Persistencia de las lesiones causadas al ADN por agentes alquilantes, involucradas en la producción de intercambios de cromátides hermanas. Revista Especializada en Ciencias de la Salud, 3, 3-13.
 
[6]Katzung, B.G. (1996) Farmacología Básica y Clínica. El Manual Moderno, México.
 
[7]Arce, C., Martínez-Tlahuel, J. and Lara, F.U. (2006) Quimioterapia adyuvante en cáncer de mama: Presente y futuro. Cancerología, 1, 177-185.
 
[8]Banerjee, A. and Benedict, W.F. (1979) Production of Sister Chromatid Exchanges by Various Cancer Chemotherapeutic Agents. Cancer Research, 39, 797-799.
 
[9]López-Nigro, M.M. and Carballo, M.A. (2008) Los nitroimidazoles como modelo de mutagénesis química y muerte celular. Theoria, 17, 47-62.
 
[10]Uribe-Alcocer, M. and Díaz-Jaimes, J.P. (2001) Fish Chromosomes as Biomarkers of Genotoxic Damage and Proposal for the Use of Tropical Catfish Species for Short-Term Screening of Genotoxic Agents. Environmental Science Research, 56, 361-390.
 
[11]Brugés, R., Guzmán, L.H., Sánchez, O., Díaz, S. and Vergara, E. (2009) Neoadyuvancia en cáncer de mama. Revista Colombiana de Cancerología, 13, 157-174.
http://dx.doi.org/10.1016/S0123-9015(09)70134-9
 
[12]Jones, S.E., Durie, B.G.M. and Salmon, S.E. (1975) Combination Chemotherapy with Adriamycin and Cyclophosphamide for Advanced Breast Cancer. Cancer, 36, 90-97.
http://dx.doi.org/10.1002/1097-0142(197507)36:1<90::AID-CNCR2820360104>3.0.CO;2-H
 
[13]SEGOB (2012) Norma oficial mexicana NOM-012-SSA3-2012, Que establece los criterios para la ejecución de proyectos de investigación para la salud en seres humanos.
http://dof.gob.mx/nota_detalle.php?codigo=5284148&fecha=04/01/2013
 
[14]WMA (2013) Helsinki Declaration. http://www.wma.net/es/30publications/10policies/b3/
 
[15]Moorhead, P.S., Nowell, P.C., Mellman, W.J., Battips, D.M. and Hungerford, D.A. (1960) Chromosome Preparations of Leukocytes Cultured from Human Peripheral Blood. Experimental Cell Research, 20, 613-616. http://dx.doi.org/10.1016/0014-4827(60)90138-5
 
[16]Perry, P. and Wolff, S. (1974) New Giemsa Method for the Differential Staining of Sister Chromatids. Nature, 251, 156-158. http://dx.doi.org/10.1038/251156a0
 
[17]Krishna, G., Xu, J., Nath, J., Petersen, M. and Ong, T. (1985) In Vivo Cytogenic Studies on Mice Exposed to Ethylene Dibromide. Mutation Research/Genetic Toxicology, 158, 81-87. http://dx.doi.org/10.1016/0165-1218(85)90101-6
 
[18]Pérez-Herrera, N., Ceballos-Quintal, J.M. and Pinto-Escalante, D. (1996) Prevalencia de intercambio de cromátides hermanas en una población libre de exposición a agentes clastogénicos. Revista Biomédica, 10, 71-76.
 
[19]Ostrosky-Wegman, P. and Gonsebatt, M.E. (1997) Biomarcadores moleculares en la determinación de efectos xenobióticos. Gaceta Médica de México, 133, 93-96.
 
[20]Ocampo, A.P., Hoyos, L.S. and Carvajal, S. (2001) Medición del da?o genético inducido por el Basuco en linfocitos humanos empleando la prueba de micronúcleos con citocalasina b. Acta Biológica Colombiana, 6, 59-66.
 
[21]Poblete, M.T. (2002) Marcadores de utilidad en cáncer mamario. Cuadernos de Cirugía, 15, 74-79. http://dx.doi.org/10.4206/cuad.cir.2001.v15n1-14
 
[22]Figueroa, L., Bargallo, E., Castorena, G. and Valancia, S. (2009) Cáncer de mama familiar, BRCA1 positivo. Revista Chilena de Cirugía, 61, 547-551. http://dx.doi.org/10.4067/S0718-40262009000600010
 
[23]Hick, A.S., Paczkowski, M.G., Gadano, B.A. and Carballo, M.A. (2007) Biomarcadores de genotoxicidad en individuos expuestos a arsénico. Latin American Journal of Pharmacy, 26, 691-699.
 
[24]Gallardo, J., Rubio, B., Baraja, O., González, C. and Cunill, E. (2001) Quimioterapia en Cáncer de mama Qué drogas? Cuánto Cuántas? Revista Hospital Clínico Universidad de Chile, 12, 134-146.      eww150206lx
标签：

评论

发表评论

此博客中的热门博文

A Comparison of Methods Used to Determine the Oleic/Linoleic Acid Ratio in Cultivated Peanut (Arachis hypogaea L.)

Cultivated peanut ( Arachis hypogaea L.) is an important oil and food crop. It is also a cheap source of protein, a good source of essential vitamins and minerals, and a component of many food products. The fatty acid composition of peanuts has become increasingly important with the realization that oleic acid content significantly affects the development of rancidity. And oil content of peanuts significantly affects flavor and shelf-life. Early generation screening of breeding lines for high oleic acid content greatly increases the efficiency of developing new peanut varieties. The objective of this study was to compare the accuracy of methods used to classify individual peanut seed as high oleic or not high oleic. Three hundred and seventy-four (374) seeds, spanning twenty-three (23) genotypes varying in oil composition (i.e. high oleic (H) or normal/not high oleic (NH) inclusive of all four peanut market-types (runner, Spanish, Valencia and Virginia), were individually tested ...
发表评论
阅读全文

Location Optimization of a Coal Power Plant to Balance Costs against Plant’s Emission Exposure

Fuel and its delivery cost comprise the biggest expense in coal power plant operations. Delivery of electricity from generation to consumers requires investment in power lines and transmission grids. Placing a coal power plant or multiple power plants near dense population centers can lower transmission costs. If a coalmine is nearby, transportation costs can also be reduced. However, emissions from coal plants play a key role in worsening health crises in many countries. And coal upon combustion produces CO 2 , SO 2 , NO x , CO, Metallic and Particle Matter (PM10 & PM2.5). The presence of these chemical compounds in the atmosphere in close vicinity to humans, livestock, and agriculture carries detrimental health consequences. The goal of the research was to develop a methodology to minimize the public’s exposure to harmful emissions from coal power plants while maintaining minimal operational costs related to electric distribution losses and coal logistics. The objective was...
发表评论
阅读全文

Evaluation of the Safety and Efficacy of Continuous Use of a Home-Use High-Frequency Facial Treatment Appliance

At present, many home-use beauty devices are available in the market. In particular, many products developed for facial treatment use light, e.g., a flash lamp or a light-emitting diode (LED). In this study, the safety of 4 weeks’ continuous use of NEWA TM , a high-frequency facial treatment appliance, every alternate day at home was verified, and its efficacy was evaluated in Japanese individuals with healthy skin aged 30 years or older who complained of sagging of the facial skin.  Transepidermal water loss (TEWL), melanin levels, erythema levels, sebum secretion levels, skin color changes and wrinkle improvement in the facial skin were measured before the appliance began to be used (study baseline), at 2 and 4 weeks after it had begun to be used, and at 2 weeks after completion of the 4-week treatment period (6 weeks from the study baseline). In addition, data obtained by subjective evaluation by the subjects themselves on a visual analog scale (VAS) were also analyzed. Fur...
发表评论
阅读全文